Oral Cancer

Oral Cancer

Oral potentially malignant disorders (OPMDs) are a group of lesions or conditions that have a higher potential to develop into oral cancer. These disorders include leukoplakia, erythroplakia, oral submucous fibrosis, lichen planus, and others. 

The occurrence rate of Oral Potentially Malignant Disorders (OPMDs) in the Indian population is relatively high, especially in certain regions and population groups. According to studies, the prevalence of OPMDs in India ranges from 3.6% to 39.2%, depending on the population and diagnostic criteria used. 

One of the most common OPMDs in India is oral submucous fibrosis, which is associated with the use of betel quid and tobacco. The prevalence of this condition has been reported to be as high as 7.6% in some regions of India. Other OPMDs, such as leukoplakia and erythroplakia, are also relatively common in India and are often associated with tobacco use, both smoking, and chewing. The prevalence of these conditions varies widely depending on the population group and geographic region. 

The diagnosis of OPMDs requires a clinical examination by a dentist or oral surgeon, and in some cases, a biopsy may be necessary. Today, due to a lack of resources to cover the entire population for early detection of OPMDS; there is a high rate of morbidity & mortality. 

Early detection and management of OPMDs are critical in preventing the progression of oral cancer. Overall, OPMDs represent a significant public health concern in India, and efforts to prevent and manage these conditions are a key priority. 

Objectives:

The objective of the solution is to identify individuals who may have OPMDs early on so that appropriate interventions can be initiated to prevent or manage the condition. 

Overall, the objective of the solution is screening OPMDs and improving early detection, increasing access to appropriate care, and ultimately reducing the burden of these potentially serious conditions on individuals and healthcare systems. 

Outcomes: 

Overall, implementing a solution for screening OPMDs can help improve the quality of care for individuals, reduce healthcare costs, and ultimately save lives by detecting and treating these potentially serious conditions at an early stage.